Cardiovascular education weekend: CVD burden, 33 years of change, and three new QCG subspecialists
Opening session of a Queensland Cardiovascular Group (QCG) GP education weekend — why every fourth GP visit still touches the heart, how outcomes transformed since the thrombolysis era, and which new cardiologists to think of for ACHD/pregnancy, cardio-oncology and complex coronary work.
- Primary speaker
- QCG cardiologist host (first name referenced later in the day as Rob; surname not clearly captured in Otter ASR) — opens the GP education weekend, acknowledges Traditional Custodians, sponsors and retiring founding cardiologist Dr Malcolm Davison.
- New cardiologists introduced
- Dr Mona Lewin (adult congenital heart disease + obstetric/pregnancy cardiology) · Dr Lorcan Ruan (cardio-oncology; echo across TTE/stress/TOE; heart failure & prevention interest) · Dr Maggie He (interventional cardiology — complex PCI, intravascular imaging, calcium modification). Also noted recent recruits Dr Alex Ashwood and Dr Dinesh (surname ASR-garbled).
- Session context
- Otter id
ZoN9DfPKll9bD23AuvB7KMr6nYY· title Cardiovascular Education Weekend · ~10.4 min (624 s) · Saturday morning 2026-02-28. Companion deep-dive same morning: cardiology-subspecialties.
Key messages for GPs
- ~1 in 6 Australians live with cardiovascular disease (~4.5 million); about one quarter of GP visits involve at least one cardiovascular problem.
- Patients now expect to live well with excellent outcomes — the bar for counselling and shared decisions is higher than a generation ago.
- Care moved from “thrombolysis and hope” (STEMI mortality framed ~15–20% in early 1990s) to primary PCI networks, drug-eluting stents, SGLT2/GLP-1, TAVI/mitral clips, CT calcium scores, cardiac MRI, leadless pacemakers and pulsed-field AF ablation.
- Wearables mean the next decade’s patient may arrive with trend data, a genome and an AI differential — health literacy and anxiety still need a GP, not a device.
- Know your referral map: ACHD/pregnancy (Lewin), cardio-oncology (Ruan), complex intervention (He).
Australian CVD burden in the consulting room
The host opened with a respectful Acknowledgement of Country, then the familiar but still-useful scale numbers: cardiovascular disease is still one of the great challenges in Australian healthcare. With roughly one in six people living with CVD and about a quarter of GP encounters involving a cardiovascular problem, cardiology is not a niche referral stream — it is core general practice.
When you feel “every second patient has BP/lipids/AF/chest pain triage”, the epidemiology agrees. Build systems (recalls, absolute risk, medication titration protocols) rather than relying on heroic one-off visits.
From thrombolysis to TAVI and wearables
QCG was described as in its 33rd year, with founding cardiologist Dr Malcolm Davison retiring from clinical practice (March, as stated). The career arc was used as a tour of innovation:
- Early 1990s: STEMI → thrombolysis; mortality framed ~15–20%.
- Mid-1990s onward: coronary stents; then troponin assays, primary prevention focus, primary PCI networks, drug-eluting stents, ICD uptake, early complex ablation.
- Now: much lower coronary mortality; toolbox includes statins, SGLT2 inhibitors, GLP-1 agonists, transcatheter valves, mitral clips, advanced imaging (CT calcium score, cardiac MRI), leadless pacemakers, pulsed-field AF ablation, and consumer wearables that can record a medical-grade ECG from a wrist.
Better outcomes, higher health anxiety
A useful paradox for the consulting room: disease burden is lower, but health anxiety is often higher. Prediction offered: the patient walking in 10 years from now may know more about their heart than any patient in history — trend data from wearables, a fully sequenced genome, and an AI-generated list of possible diagnoses. Literacy gaps and anxiety will still dominate. GPs remain the interpreters and the “is this urgent?” filter.
Smartwatch AF alerts and “AI differentials” can trigger cascades. Anchor on symptoms, pretest probability, and guideline pathways — not on the longest list the algorithm printed.
Three new QCG subspecialists — who to call
| Cardiologist | Subspecialty lens | Think of them when… |
|---|---|---|
| Dr Mona Lewin | Adult congenital heart disease (ACHD); obstetric / pregnancy cardiology; advanced TTE/TOE including peri-procedural/structural imaging; pulmonary hypertension & aortopathy interest | Grown-up congenital lesions, pregnancy counselling in known heart disease, complex echo questions around ACHD |
| Dr Lorcan Ruan | Cardio-oncology (formal training — described as uncommon in Australia); echo suite; heart failure & prevention | Active or past cancer therapy with CV risk, cardiotoxic regimens, survivorship CV optimisation |
| Dr Maggie He | Interventional cardiology — ACS/PCI, complex/high-risk cases, intravascular imaging, physiology, calcium modification; prevention mindset | Coronary assessment/intervention pathways, complex calcium/physiology cases needing clear GP↔cath-lab communication |
Clinic takeaways
- Update your “who do I ring?” list for pregnancy + heart disease, cancer survivors with CV risk, and complex coronary anatomy — not only “general cardiology”.
- When patients bring wearable ECGs or AI symptom lists, thank the data, then re-centre on history, exam and absolute risk.
- Celebrate progress (mortality down) without dismissing modern anxiety — acknowledge fear, then give a concrete next step.
- Same-day deeper clinical content continues in the cardiology subspecialties write-up (ACHD case + cardio-oncology survivorship).